Sara Ganzhorn

The cyclic AMP pathway is a sex-specific modifier of glioma risk in type I neurofibromatosis patients.

T. Druley, N. Warrington, Jingqin Luo, 2015, Cancer research.

The cyclic AMP pathway is a sex-specific modifier of glioma risk in type I neurofibromatosis patients.

Karlyne M. Reilly, T. Druley, N. Warrington, 2015, Cancer research.